Tech Company Financing Transactions

System1 Biosciences Funding Round

System1 Biosciences closed a $25 million Series A financing round on 9/13/2018. Investors included CRV, Pfizer Venture Investments and Alexandria Venture Investments.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1405 Minnesota St.
San Francisco, CA 94107
USA

Phone

(929) 575-5579

Website

www.system1.bio

Email Address

[email protected]

Overview

System1 Biosciences, Inc., is a San Francisco-based neurotherapeutics company that employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia, disorders for which current discovery techniques have proved least successful.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Sean Escola

        

Browse more venture capital transactions:

Prev: 9/13/2018: Burlywood venture capital transaction
Next: 9/13/2018: SiSense venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary